Dongyu Sheng

530 total citations
15 papers, 426 citations indexed

About

Dongyu Sheng is a scholar working on Molecular Biology, Physiology and Biomaterials. According to data from OpenAlex, Dongyu Sheng has authored 15 papers receiving a total of 426 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Physiology and 4 papers in Biomaterials. Recurrent topics in Dongyu Sheng's work include Alzheimer's disease research and treatments (7 papers), RNA Interference and Gene Delivery (3 papers) and Nanoparticle-Based Drug Delivery (3 papers). Dongyu Sheng is often cited by papers focused on Alzheimer's disease research and treatments (7 papers), RNA Interference and Gene Delivery (3 papers) and Nanoparticle-Based Drug Delivery (3 papers). Dongyu Sheng collaborates with scholars based in China and South Korea. Dongyu Sheng's co-authors include Qizhi Zhang, Kang Qian, Pengzhen Wang, Shuting Xu, Qian Guo, Yunlong Cheng, Peng Yang, Jinxu Cao, Yixian Li and Liuchang Wang and has published in prestigious journals such as ACS Nano, Biomaterials and Journal of Controlled Release.

In The Last Decade

Dongyu Sheng

15 papers receiving 419 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dongyu Sheng China	10	185	124	119	98	61	15	426
Jinxu Cao China	11	167 0.9×	113 0.9×	126 1.1×	78 0.8×	55 0.9×	16	394
Yixian Li China	9	139 0.8×	125 1.0×	79 0.7×	91 0.9×	65 1.1×	20	369
Mehdi Sanati Iran	15	238 1.3×	116 0.9×	122 1.0×	123 1.3×	41 0.7×	35	600
Huahua Song China	8	257 1.4×	84 0.7×	130 1.1×	110 1.1×	40 0.7×	14	476
Stefania Minniti Italy	7	152 0.8×	163 1.3×	141 1.2×	52 0.5×	44 0.7×	8	389
Xiaoying Pang China	7	205 1.1×	74 0.6×	155 1.3×	79 0.8×	30 0.5×	9	409
Radka Gromnicova United Kingdom	9	105 0.6×	58 0.5×	143 1.2×	90 0.9×	63 1.0×	11	346
Simona Mancini Italy	8	179 1.0×	190 1.5×	133 1.1×	56 0.6×	29 0.5×	8	415
Elisa Salvati Italy	8	261 1.4×	271 2.2×	214 1.8×	81 0.8×	48 0.8×	8	560

Countries citing papers authored by Dongyu Sheng

Since Specialization

Citations

This map shows the geographic impact of Dongyu Sheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dongyu Sheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dongyu Sheng more than expected).

Fields of papers citing papers by Dongyu Sheng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dongyu Sheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dongyu Sheng. The network helps show where Dongyu Sheng may publish in the future.

Co-authorship network of co-authors of Dongyu Sheng

This figure shows the co-authorship network connecting the top 25 collaborators of Dongyu Sheng. A scholar is included among the top collaborators of Dongyu Sheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dongyu Sheng. Dongyu Sheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Wu, Jing, Yunlong Cheng, Kang Qian, et al.. (2025). siRNA-Encapsulated Biomimetic Liposomes Effectively Inhibit Tumor Cells’ Hexosamine Biosynthesis Pathway for Attenuating Hyaluronan Barriers to Pancreatic Cancer Chemotherapy. ACS Nano. 19(8). 7928–7947. 8 indexed citations

Qian, Kang, Peng Yang, Yixian Li, et al.. (2024). Rational fusion design inspired by cell-penetrating peptide: SS31/S-14 G Humanin hybrid peptide with amplified multimodal efficacy and bio-permeability for the treatment of Alzheimer's disease. Asian Journal of Pharmaceutical Sciences. 19(4). 100938–100938. 4 indexed citations

Cheng, Yunlong, Minjun Xu, Kang Qian, et al.. (2024). Carcinoma–Astrocyte Gap Junction Interruption by a Dual-Targeted Biomimetic Liposomal System to Attenuate Chemoresistance and Treat Brain Metastasis. ACS Nano. 18(50). 34107–34125. 5 indexed citations

Xu, Minjun, Yunlong Cheng, Ran Meng, et al.. (2023). Enhancement of Microglia Functions by Developed Nano‐Immuno‐Synergist to Ameliorate Immunodeficiency for Malignant Glioma Treatment. Advanced Healthcare Materials. 12(30). e2301861–e2301861. 11 indexed citations

Li, Yixian, Peng Yang, Shuting Xu, et al.. (2023). Multidimensional autophagy nano-regulator boosts Alzheimer's disease treatment by improving both extra/intraneuronal homeostasis. Acta Pharmaceutica Sinica B. 14(3). 1380–1399. 13 indexed citations

Cao, Jinxu, Jing Wu, Peng Yang, et al.. (2023). Dual Enzyme Cascade-Activated Popcorn-Like Nanoparticles Efficiently Remodeled Stellate Cells to Alleviate Pancreatic Desmoplasia. ACS Nano. 17(20). 19793–19809. 12 indexed citations

Cheng, Yunlong, Xiaoying Pang, Jing Wu, et al.. (2023). Medium-chain triglyceride-stabilized docetaxel-loaded HSA nanoparticles effectively inhibited metastatic non-small cell lung cancer. Drug Delivery and Translational Research. 13(11). 2869–2884. 4 indexed citations

Guo, Qian, Yixian Li, Shuting Xu, et al.. (2023). Brain-neuron targeted nanoparticles for peptide synergy therapy at dual-target of Alzheimer's disease. Journal of Controlled Release. 355. 604–621. 25 indexed citations

Qian, Kang, Xiaoyan Bao, Yixian Li, et al.. (2022). Cholinergic Neuron Targeting Nanosystem Delivering Hybrid Peptide for Combinatorial Mitochondrial Therapy in Alzheimer’s Disease. ACS Nano. 16(7). 11455–11472. 67 indexed citations

10.

Yang, Peng, Qian Guo, Shuting Xu, Dongyu Sheng, & Qizhi Zhang. (2021). [Constructing Brain Aβ-Targeting Nanoparticles Loaded with EGCG for Treating Alzheimer's Disease in Mice].. PubMed. 52(4). 605–611. 1 indexed citations

11.

Cao, Jinxu, Peng Yang, Pengzhen Wang, et al.. (2020). ‘Adhesion and release’ nanoparticle-mediated efficient inhibition of platelet activation disrupts endothelial barriers for enhanced drug delivery in tumors. Biomaterials. 269. 120620–120620. 36 indexed citations

12.

Guo, Qian, Shuting Xu, Peng Yang, et al.. (2020). A dual-ligand fusion peptide improves the brain-neuron targeting of nanocarriers in Alzheimer's disease mice. Journal of Controlled Release. 320. 347–362. 73 indexed citations

13.

Yang, Peng, Dongyu Sheng, Qian Guo, et al.. (2020). Neuronal mitochondria-targeted micelles relieving oxidative stress for delayed progression of Alzheimer's disease. Biomaterials. 238. 119844–119844. 104 indexed citations

14.

Pang, Xiaoying, Peng Yang, Liuchang Wang, et al.. (2019). Human serum albumin nanoparticulate system with encapsulation of gefitinib for enhanced anti-tumor effects in non-small cell lung cancer. Journal of Drug Delivery Science and Technology. 52. 997–1007. 20 indexed citations

15.

Guo, Qian, Xiaoyao Zheng, Peng Yang, et al.. (2018). Small interfering RNA delivery to the neurons near the amyloid plaques for improved treatment of Alzheimer׳s disease. Acta Pharmaceutica Sinica B. 9(3). 590–603. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact